These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37568786)

  • 41. Prognostic Significance of Regional/Systemic Metabolic Parameters on
    Li Y; Zhang W; Zhang H; Hu J; Zhou C; Zhang X; Fan W
    Front Oncol; 2021; 11():675961. PubMed ID: 34221995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
    Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
    AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
    Hwang SH; Lee JW; Cho HJ; Kim KS; Choi GH; Yun M
    Clin Nucl Med; 2017 Jan; 42(1):34-39. PubMed ID: 27775949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of metabolic tumour volume and total lesion glycolysis in
    Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW; Lee KY; Kim HJ; Kim WS; So Y
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):89-98. PubMed ID: 24194352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma.
    Choi WR; Oh JS; Roh JL; Kim JS; Oh I; Choi SH; Nam SY; Kim SY
    Head Neck; 2019 Jun; 41(6):1846-1853. PubMed ID: 30675738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization.
    Zschaeck S; Weingärtner J; Lombardo E; Marschner S; Hajiyianni M; Beck M; Zips D; Li Y; Lin Q; Amthauer H; Troost EGC; van den Hoff J; Budach V; Kotzerke J; Ferentinos K; Karagiannis E; Kaul D; Gregoire V; Holzgreve A; Albert NL; Nikulin P; Bachmann M; Kopka K; Krause M; Baumann M; Kazmierska J; Cegla P; Cholewinski W; Strouthos I; Zöphel K; Majchrzak E; Landry G; Belka C; Stromberger C; Hofheinz F
    Front Oncol; 2022; 12():870319. PubMed ID: 35756665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
    Flach S; Howarth K; Hackinger S; Pipinikas C; Ellis P; McLay K; Marsico G; Forshew T; Walz C; Reichel CA; Gires O; Canis M; Baumeister P
    Br J Cancer; 2022 May; 126(8):1186-1195. PubMed ID: 35132238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
    Leccisotti L; Manfrida S; Barone R; Ripani D; Tagliaferri L; Masiello V; Privitera V; Gambacorta MA; Rufini V; Valentini V; Giordano A
    Ann Nucl Med; 2020 Jan; 34(1):65-73. PubMed ID: 31728763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    Woff E; Hendlisz A; Ameye L; Garcia C; Kamoun T; Guiot T; Paesmans M; Flamen P
    J Nucl Med; 2019 Feb; 60(2):178-184. PubMed ID: 29959212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
    Im HJ; Kim YK; Kim YI; Lee JJ; Lee WW; Kim SE
    Nucl Med Mol Imaging; 2013 Mar; 47(1):36-43. PubMed ID: 24895506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
    Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Metabolo-Volumetric Parameters of
    Surov A; Meyer HJ; Höhn AK; Sabri O; Purz S
    Transl Oncol; 2019 Jan; 12(1):8-14. PubMed ID: 30240972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Volumetric parameters of the primary tumor and whole-body tumor burden derived from baseline
    Mahmoud HA; Oteify W; Elkhayat H; Zaher AM; Mohran TZ; Mekkawy N
    Eur J Hybrid Imaging; 2022 Dec; 6(1):37. PubMed ID: 36575330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients.
    Li YM; Lin Q; Zhao L; Wang LC; Sun L; Dai MM; Luo ZM; Zheng H; Wu H
    Asian Pac J Cancer Prev; 2014; 15(3):1369-73. PubMed ID: 24606467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.